Sort
40,608 grants matching “prostate cancer”
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$459,263Mobile Infirmary Medical Center · U10 · FY2003 · CA
Tumor Immunology & Host Response
$459,262Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2013 · CA
Lectin Resistant Tumor Cells and Functional Glycomics
$459,250Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2019 · GM
Lectin Resistant Tumor Cells and Functional Glycomics
$459,250Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2020 · GM
SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT) FOR PROSTATE CANCER
$459,204E David Crawford · University Of Colorado Denver · M01 · FY2006 · RR
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer
$459,197Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2007 · CA
Whole Genome Association Study of Mammographic Density
$459,193Rulla M Tamimi · Brigham And Women'S Hospital · R01 · FY2009 · CA
NOVEL OPTICAL METHODS FOR IDENTIFICATION, IMAGING, PRESERVATION OF CAVERNOUS NERVES RESPONSIBLE FOR PENILE ERECTIONS DURING PROSTATE CANCER SURGERY
$459,158University Of North Carolina At Charlotte · · FY2008 · Department of Defense
Serum Antibody Profiling with a Carbohydrate Microarray
$459,103Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Stress Induction of Glucose Regulated Protein GRP78/BiP
$459,080Amy S Lee · University Of Southern California · R01 · FY2012 · CA
Genomic Imprinting in Cancer
$459,042Andrew P Feinberg · Johns Hopkins University · R01 · FY2007 · CA
Probe Optimization for Prostate Cancer Detection
$459,037Clifford Berkman · Washington State University · R01 · FY2012 · CA
IMPACT OF MARYLAND'S ALL-PAYER MODEL ON RACIAL AND SOCIOECONOMIC DISPARITIES IN PROSTATE CANCER MANAGEMENT
$458,955New York University · · FY2025 · Defense Health Agency
Biomarkers for Prostate and Bladder Cancer
$458,951University Of Washington · U01 · FY2005 · CA
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer
$458,934Philip W Kantoff · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA
HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE
$458,895Erkki I Ruoslahti · Sidney Kimmel Cancer Center · P01 · FY2007 · CA
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
$458,880Celine Dermardirossian · San Diego Biomedical Research Institute · R01 · FY2018 · CA
Geisinger Clinical Oncology Program
$458,852Albert Michael Bernath · Geisinger Medical Center · U10 · FY2007 · CA
PSMA-VRP vaccine for prostate cancer
$458,795William C Olson · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · CA
Proteomics Biomarkers Development Laboratory
$458,633Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2008 · CA
Molecular Recognition of Proteins and Ligand Design
$458,593William Jorgensen · Yale University · R01 · FY2020 · GM
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$458,591Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Cancer Immunotherapy Clinical Trials
$458,587Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$458,577Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2021 · CA
Human Leukemia Growth Inhibition by a Novel Retinoid
$458,562Joseph A Fontana · Wayne State University · R01 · FY2007 · CA